About the Authors
- Zul Premji
-
* E-mail: zpremji@muhas.ac.tz
Affiliation Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
- Rich E. Umeh
-
Affiliation College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
- Seth Owusu-Agyei
-
Affiliation Kintampo Health Research Center, Kintampo, Ghana
- Fabian Esamai
-
Affiliation Department of Child Health and Paediatrics, School of Medicine, Moi University, Eldoret, Kenya
- Emmanuel U. Ezedinachi
-
Affiliation Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria
- Stephen Oguche
-
Affiliation Department of Paediatrics, Faculty of Medical Sciences, University of Jos/ Jos University Teaching Hospital (JUTH), Jos, Nigeria
- Steffen Borrmann
-
Affiliations Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Kilifi, Kenya, University of Heidelberg School of Medicine, Heidelberg, Germany
- Akintunde Sowunmi
-
Affiliation Malaria Research Laboratories, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria
- Stephan Duparc
-
Affiliation Medicines for Malaria Venture, Geneva, Switzerland, formerly at GlaxoSmithKline, Greenford, Middlesex, United Kingdom
- Paula L. Kirby
-
Affiliation GlaxoSmithKline, Stockley Park West, Middlesex, United Kingdom
- Allan Pamba
-
Affiliation GlaxoSmithKline, Greenford, Middlesex, United Kingdom
- Lynda Kellam
-
Affiliation GlaxoSmithKline, Greenford, Middlesex, United Kingdom
- Robert Guiguemdé
-
Affiliation Center Muraz, Bobo-Dioulasso, Burkina Faso
- Brian Greenwood
-
Affiliation Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Stephen A. Ward
-
Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- Peter A. Winstanley
-
Affiliation School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
Competing Interests
The authors declare no conflict of interest other than P L Kirby, A Pamba and L Kellam who are employed by GlaxoSmithKline PLC and S Duparc who was employed by GlaxoSmithKline PLC at the time of the study and is now employed by the Medicines for Malaria Venture as stated in the affiliations.
Author Contributions
Conceived and designed the experiments: SD PLK AP BG SW PW. Performed the experiments: ZP REU SOA FE EUE SO SB AS RG. Analyzed the data: ZP REU SOA FE EUE SO SB AS SD AP LK RG BG SW PW. Wrote the paper: ZP AP LK. Critically reviewed the paper: REU SOA FE EUE SO SB AS SD PLK RG BG SW PW. Approved the final version of the paper: ZP REU SOA FE EUE SO SB AS SD PLK AP LK RG BG SW PW.